MedTrace Logo

Learning to Evaluate Blood Pressure at Home (LEANBH)

NCT04671602 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-12-17

No results posted yet for this study

Summary

COVID-19 has highlighted important deficiencies in our health service where front line staff and pregnant women are being exposed to SARS-Cov-2 through assessments that could be conducted using Connected Health solutions, reducing risks of contracting or disseminating SARS-Cov-2. Currently, pregnant women are not attending GPs or hospitals for BP monitoring for fear of contracting SARS-Cov-2. Uncontrolled or unmonitored hypertension in pregnancy is associated with maternal and fetal morbidity and mortality. The aim of the study is to use home BP monitoring as an adjunct to standard care for women with borderline/suspected hypertension in pregnancy. To reduce the exposure risk for staff and pregnant women, we propose the immediate implementation of ambulatory automated self BP monitoring using the LEANBH platform- an existing integrated platform to monitor pregnant women.

Conditions

  • Hypertension in Pregnancy

Sponsors & Collaborators

  • Science Foundation Ireland

    collaborator OTHER

  • University College Cork

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-19
Primary Completion
2021-02-28
Completion
2021-08-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04671602 on ClinicalTrials.gov